BlackRock Capital Allocation Term Trust (BCAT) to Distribute Monthly Dividend of $0.25 on August 31st

BlackRock Capital Allocation Term Trust (NYSE:BCAT) announced a monthly dividend on Friday, June 5th. Shareholders of record on Friday, August 14th will be given a dividend of 0.2542 per share on Monday, August 31st. This represents a c) annualized dividend and a yield of 19.0%. The ex-dividend date is Friday, August 14th.

BlackRock Capital Allocation Term Trust Stock Down 0.2%

BCAT opened at $16.08 on Wednesday. BlackRock Capital Allocation Term Trust has a 12-month low of $13.73 and a 12-month high of $16.20. The business has a 50 day moving average of $15.77 and a 200-day moving average of $15.25.

Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust

Several hedge funds have recently added to or reduced their stakes in the business. Geneos Wealth Management Inc. raised its position in shares of BlackRock Capital Allocation Term Trust by 341.7% in the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock valued at $31,000 after purchasing an additional 1,582 shares during the period. N.E.W. Advisory Services LLC grew its stake in BlackRock Capital Allocation Term Trust by 100.0% in the 4th quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after buying an additional 1,200 shares during the last quarter. McIlrath & Eck LLC grew its stake in BlackRock Capital Allocation Term Trust by 169.6% in the 1st quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock valued at $44,000 after buying an additional 1,969 shares during the last quarter. Parallel Advisors LLC bought a new position in BlackRock Capital Allocation Term Trust in the 3rd quarter valued at about $47,000. Finally, Brown Brothers Harriman & Co. raised its holdings in BlackRock Capital Allocation Term Trust by 450.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock valued at $81,000 after acquiring an additional 4,500 shares during the period. Institutional investors and hedge funds own 36.12% of the company’s stock.

BlackRock Capital Allocation Term Trust Company Profile

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.